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The degree of oxidative stress can be determined by measuring hydrogen peroxide
(H2O2) concentration in exhaled breath condensate (EBC) but the methods to
measure H2O2 are all rather time consuming and only reliable and/or accurate in the
hand of skilled technicians in a dedicated laboratory.
We tested a new commercial device (EcocheckTM), developed to offer a less time-
consuming method to measure H2O2. We validated this new method according the
NCCLS EP10-A2 protocol. The validation shows that the imprecision in the low range
is high (28.4%) and declines with higher concentrations of H2O2 (up to 6.6%). The
EcocheckTM is
’ ’
an easy to use’’ measuring device for routine measurements getting
quick results without the need for skilled technicians to determine H2O2
concentrations.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Inflammatory processes in the lung elicit so called
oxidative stress, meaning that the integrity of the
lung is jeopardized by oxidants, and the latterElsevier Ltd. All rights reserv
6092139;
ius.net (W.B. Gerritsen).process is supposed to play an important role in the
development of chronic obstructive pulmonary
disease (COPD).1 Oxidative stress is known to be
increased in both stable and unstable COPD
patients, due to either exposure to exogenous
oxidants as present in cigarette smoke, in
air pollution or as an enhanced endogenous
production of hydrogen peroxide (H2O2) due to
a neutrophilic inflammation and an impaireded.
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Table 1 Reagents and supplies EcocheckTM.
Reagents Concentration Art. nr.
Buffer-kit includes 992589
1000ml phosphate
buffer bottle
18mmol/l
200ml dilution
buffer bottle
36mmol/l
Calibration-kit
includes
992588
Reagents 1
Reagents 2
100 H2O2 biosensor
layout G
992592
Hydrogen peroxide biosensor 1133antioxidant system.2–4 The degree of oxidative
stress is determined by measuring the H2O2
concentration in exhaled breath condensate (EBC).
There are several methods available to measure
H2O2 in breath condensate, but these methods are
all rather time consuming and only reliable/
accurate in the hand of skilled technicians in a
dedicated laboratory.
A new device (EcocheckTM) claims to offer a less
time consuming method to measure H2O2. Accord-
ing to the manufacturer, also non-skilled (lung
function) technicians should be able to perform the
measurements, in EBC after a short training. We
validated this new method according to the
National Committee for Clinical Laboratory Stan-
dards (NCCLS) EP10-A2 guidelines to make a
preliminary decision about its acceptability.5
Furthermore, we checked the following para-
meters: the detection limit and the comparability
of a population of smoking and non-smoking
controls and patients with stable COPD with an
existing spectrofluorimetric method.6Materials and methods
Measuring/collection equipment
Principle of the EcocheckTM
The EcocheckTM (Filt GmbH, Berlin, Germany) is a
device using a biosensor and developed for measur-
ing H2O2 concentrations in EBC in a range from 15 to
10,000 nmol/l with an accuracy of 5%, both claimed
by the manufacturer.
H2O2 is reduced enzymatically by peroxidase,
present on the sensor. The enzyme peroxidase
transfer electrons, set free by the reduction of
H2O2 into water, to a mediator which in its turn
converts from a reduced into an oxidized state.
That conversion induces an electron transfer
between the mediator (sensor) and an electrode,
and the mediator will return to its reduced form.
The degree of electron transfer, measured by an
amperometer, is proportional to the H2O2 concen-
tration.Reagents
For measuring, the following supplies are needed:
biosensors, calibration kit, buffer kit and disposa-
ble syringes of 1, 2 and 20ml. The specifications of
the reagents are shown in Table 1. All reagents are
purchased from Filt GmbH Lung and Chest Com-
pany, Berlin, Germany.Preparation of the reaction solution
Buffer-kit: Reconstitute the phosphate buffer in
600ml HPLC grade water, and transfer 100ml out of
this phosphate buffer bottle into the dilution buffer
bottle (final concentration 36mmol/l). Fill the
phosphate buffer bottle up to 1000ml (final
concentration 18mmol/l). The phosphate and
dilution buffer must be sonificated for half an hour
before use to remove entrapped air. Store both
buffers in a refrigerator at 4–10 1C for a maximum
of 2 months.
Calibration-kit: Reconstitute reagent 1 with
20ml phosphate buffer (18mmol/l). Prepare re-
agent 2 just before measurement by pipetting
1.5ml reagent 1 into bottle reagents 2. The
calibration solutions had to be freshly prepared
every day.
Each sensor needs its own calibration.
Preparing of the exhaled breath condensate
sample (EBC)
Dilute the EBC 1:1 with dilution buffer (36mmol/l)
and mix well. Mix 500 ml EBC with 500 ml dilution
buffer (36mmol/l) gentle in a plastic tube. In case
of non-sufficient sample dilute always with the
same amount dilution buffer, because ionic
strength of the mixture is very important for
correct measuring results.
Spectrofluorimetric method
Briefly, this method is based on the reaction of H2O2
with the enzyme horseradish peroxidase described
by van Beurden et al.6 The substrate para-hydro-
xyphenylacetic acid is oxidized to a fluorimetric
dimer 2,2-dihydroxybiphenyl-5,5-diacetate.
The fluorescence of the reaction product 2,2-
dihydroxybiphenyl-5,5-diacetate was measured
with an excitation wavelength of 295 nm and an
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W.B. Gerritsen et al.1134emission wavelength of 405 nm on a Kontron SFM
fluorimeter (Kontron Instruments, Beun de Ronde,
the Netherlands).
Collection of EBC
EBC was collected via a special cooling device the
EcoscreenTM (Jaeger, Wurzberg, Germany). The
EcoscreenTM allows for non-invasive sampling of
non-gaseous and dissolved substances contained in
the expired air such as aerosol and water vapour.
The sample contains mainly metabolic products
from the airways and the lung but it also contain
products of other organs, which reach the lungs via
the bloodstream.7,8
This collecting device consists of a cold trap
(counter current principle) to condense exhaled
breath at 10 1C. The collected breath condensate
volumes varied from about 2–7ml (mean 3.2ml)
during 15min sampling.
NCCLS EP10-A2 protocol approach5
Scope: Before using a new method, kit or instru-
ment for in vitro diagnostic use, it is necessary to
make a decision about its acceptability. This initial
performance check is neither a rigorous investiga-
tion into the method’s long-term performance nor
an evaluation of the many factors that can affect
results produced by the device. The primary
purpose of this document is to help the user to
detect problems that are severe enough to warrant
immediate correction, referral to the manufac-
turer, or expanded investigation. Preliminary eva-
luations should be performed before new methods
are used to test patients’ samples and when any
modifications of methods are made. The NCCLS
EP10-A2 document describes a procedure for the
evaluation of linearity, proportional and constant
bias, linear drift, sample carry-over, and precision
of a clinical laboratory method.
The protocol is intended primarily for evaluating
automated instruments but may be appropriate for
kits, manual procedures or other in vitro diagnostic
devices. By repeating a sequence of only 10
samples, performance characteristics may be eval-
uated by plotting the data and performing some
simple calculations namely multiple linear regres-
sion analysis. From these calculations, some further
information about the factors influencing accuracy
such as carry-over and linear drift are obtained.
Validation according to the NCCLS EP10-A2
protocol was based on 6 days measuring H2O2
concentrations at three different levels low, med-
ium and high in a fixed setting. The H2O2 levels
were prepared from a 30% H2O2 stock solution
(Sigma-Aldrich Chemie b.v. Zwijndrecht, the Neth-
erlands). The following concentrations were used:(1) low level 87 nmol/l, (2) medium level 480 nmol/
l and (3) high level 873 nmol/l and a calibration
level of 500 nmol/l. The fluids were prepared
freshly every day from the stock solution and used
immediately after preparation. The measurements
were run every morning at 9:00 h in the following
way: medium, high, low, medium, medium, low,
low, high, high and medium level, directly after
each other.
Statistical analysis
Data are expressed as mean7SD deviations.
Statistical analysis was performed using the paired
t-test. The correlation was calculated using
Bablok–Passing orthogonal regression analysis.
A Po0:05 indicates a significant difference.Results
The validation report shows that the imprecision,
the dispersion of independent results of measure-
ments obtained under specified conditions,
’ ’
over-
all days’’ of the EcocheckTM is high (28.4%) in the
range of the low level (87 mmol H2O2 pro litre). The
imprecision declines with increasing levels of H2O2
to 15.9% at a concentration of 480 mmol H2O2 pro
litre up to 6.6% at the high level of 873 mmol H2O2
pro litre.
Multiple regression analysis with all data gave an
average of each parameter estimate and whether
each parameter estimate is significant according to
a one-sample sign test (data are presented in Table
1, t ¼ calculated statistic to test the significance).
None of these parameters are significant (P ¼ 0:01;
4.64to4.6; t for 4 degrees of freedom). The
percent sample carry-over is not detectable differ-
ent from zero although very small. On day 3, there
were some outliers, namely the intercept, slope
and nonlinearity (data not shown) for the medium
and high level. These results were discarded by the
overall day’s output. The results of the validation
of the EcocheckTM are presented in Table 2.
Linearity and detection limit of the
EcocheckTM
We checked the linearity of the biosensor in the
clinical range from 0 to 4000 nmol/l with dilutions
of the 30% H2O2 stock standard. The regression line
was y ¼ 0:9436x þ 22:73; r ¼ 0:9999:
The detection limit was calculated as mean of
the blank (HPLC grade water 1:1 diluted with
36mmol/l phosphate buffer, presented as sample,
n ¼ 10) plus three times SD (of the blank). The
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Table 2 NCCLS EP-10A2 worksheet.
Version 2003.2
Test Hydrogen peroxide
Material Aquaous solution
Instrument EcocheckTM
Methodology Biosensor
Evaluation date 1 April 2004
Level Concentration (nmol/l) Bias (nmol/l) Imprecision (%)
Low 87 13 28.4
Medium 480 39 15.9
High 873 5 6.6
Measuring results
Ranking Level Day 1 Day 2 Day 3 Day 4 Day 5 Day 6
0 Medium 439 593 651 496 546 518
1 High 736 921 972 839 905 892
2 Low 81 97 96 95 100 121
3 Medium 512 450 692 518 516 530
4 Medium 362 420 655 562 517 563
5 Low 70 56 99 107 145 128
6 Low 70 60 93 102 151 130
7 High 909 859 953 831 872 829
8 High 846 845 948 915 838 896
9 Medium 433 473 583 508 528 518
Calculations
Low Medium High
Day Mean SDwithin run Mean SDwithin run Mean SDwithin run
1 73.7 6.4 435.7 75 830.3 87.6
2 71 22.6 447.7 26.6 875 40.4
3 96 3 643.3 55.4 957.7 12.7
4 101.3 6 529.3 28.7 861.7 46.4
5 132 27.9 520.3 6.7 871.7 33.5
6 126.3 4.7 537 23.3 872.2 37.6
Calculations overall days
Parameter Low Medium High
Grand mean 100.1 518.9 878.1
Labeled value 87 480 873
Bias 13.1 38.9 5.1
VCtotal imprecision 28.4 15.9 6.6
Results multiple regression analysis
Intercept Slope %carryover Nonlinearity Drift Sy ;x
Overall days B0,adj B1,adj B2,adj B3 B4
Value 23.329 0.991 0.996 30.249 0.886 35.097
t 2.798 0.088 0.237 1.934 0.596
Characteristics used in the validation report:
 Bias: difference between the expectation of a test result or measurement result and a true value (bias ¼ grand mean
minus labelled value).
 Imprecision: dispersion of independent results of measurements obtained under specified conditions.
 Grand mean: overall mean calculated after multiple runs or days of analysis.
 Difference plot: a plot of differences between measured value and reference concentrations plotted on the y-axis
versus the reference concentration on the x-axis.
 Linear drift: a change in measurement value over time due to factors other than the concentration of the analyte
being measured.
 Labelled value: reference value.
 t ¼ calculated statistics to test the significance; P ¼ 0:01 for 4.64to4.6.
Hydrogen peroxide biosensor 1135
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1.6 nmol/l, SD 15.7 nmol/l).
Hydrogen peroxide in healthy smoking and
non-smoking controls and stable COPD
patients
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Figure 1 Orthogonal regression line of hydrogen per-
oxide concentrations of the EcocheckTM versus a spectro-
fluorimetric method.ten healthy smoking (4 female and 6 male
controls with a mean age7SD from 40.1710.4
years) and ten healthy non-smoking controls (3
female and 7 male controls with a mean age7SD
from 32.479.0 years). The mean results of the
H2O2 concentration from the non-smoking com-
pared to the smoking controls were significant
lower (P ¼ 0:013) namely 33.373.9 nmol/l (re-
sult obtained by extrapolation if below detection
limit), respectively, 161.1711.5 nmol/l, measured H2O2 in 10 COPD patients (2 female
and 8 male, mean age7SD of 70.3710.1 year).
The mean results for the COPD patients were
240.1713.5 nmol/l. This differs significantly
from the healthy controls, smokers and non-
smokers (Po0:001).
Comparison EcocheckTM with a
spectrofluorimetric methodology
We checked the comparability of the EcocheckTM
and the spectrofluorimetric method using the
results obtained from the healthy smokers and
non-smokers, and the stable COPD patients. All
concentrations below the detection limit were
discarded. We found a mean H2O2 concentration
of 164.97125.9 nmol/l for the EcocheckTM and
143.87110.2 nmol/l for the spectrofluorimetric
assay. The correlation calculated by Bablok/Passing
orthogonal regression gave the following result:
y ¼ 0:848x þ 0:199; r ¼ 0:975; N ¼ 27; Cusum test
presents the regression results using the structural
relationship and linear models and shows no
significant deviation from linearity with a mean
difference (md(95)) ¼ 36.327 nmol/l, and thereby
are all measuring points equally divided over the
regression line (Fig. 1).Discussion
The validation report, according the NCCLS EP10-
A2 protocol, shows that the imprecision in the low
range is high. The imprecision declines with higherconcentrations of H2O2. Despite the high impreci-
sion in the low range there is no discussion about
the impact on the clinical question. A high
variability means that the range of H2O2 levels in
healthy subjects (with low levels) is large and the
latter will mean that H2O2 levels in diseased
subjects must rise considerably to detect diseased
subjects. It is shown that with this method
differences between smokers and non-smokers
can be detected.
The measurement in stable COPD patients and in
smoking controls lead to significant differences in
rather small groups, which indicates rather low
overlap of the measured values. This means that
this rise in H2O2 levels in patients is strong and
pathological H2O2 levels are easily detectable
despite the variability at low levels.
The output
’ ’
overall days’’ as a result of multiple
regression analysis shows the average of each
parameter estimated and whether each parameter
estimate is significant according to a one-sample
sign test.
We conclude that none of the parameters of the
multiple regression analysis is significantly differ-
ent. If the bias, imprecision, and plot of the data
appear to be within specifications, the instrument
or method can be judged as acceptable, and this
initial screening of the quality of the instrument/
method is finished. Further and ongoing evaluation
of the usefulness of the instrument/method in the
individual laboratory is based on other, more long-
term evaluations.
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Hydrogen peroxide biosensor 1137The detection limit of the EcocheckTM is compar-
able with the detection limit of spectrofluorimetric
methodologies and much lower than spectrometric
methods (detection limit7100 nmol/l).4 The line-
arity of the biosensor goes up to 4000 nmol/l and is
more than high enough to obtain results in the
clinical range. The correlation with the spectro-
fluorimetric method is good and the results derived
from the control group and stable COPD patient
group are comparable with the results from other
research groups.2–4Conclusion
The preliminary validation of the instrument/
method is acceptable according to the NCCLS
EP10-A2 protocol. Further evaluation should be
done by measuring more patients and compare
these results with other methodologies. A part of
criticism is still that there is no quality check to
control the biosensors for deviates in day-to-day
reproducibility, near the fact that this will increase
the costs.
The EcocheckTM is
’ ’
an easy to use’’ measuring
device getting quick results and can be used by
non-skilled technicians to determine hydrogen
peroxide concentrations.References
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